Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of SU011248 for Maintenance Therapy in Hormone Refractory Prostate Cancer After First Line Chemotherapy

NCT00550810 is registered in ClinicalTrials.gov with Alberta Health services as lead sponsor.

NCT NCT00550810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00550810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of SU011248 for Maintenance Therapy in Hormone Refractory Prostate Cancer After First Line Chemotherapy
Lead sponsor
Alberta Health services
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2007
Completion date
November 30, 2012
Enrollment
30 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hormone refractory, prostate cancer